February, 2024
February 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
26272829  
Still no role for targeting PI3K pathway in mCRPC – Arun Azad
Jun 24, 2023, 18:25

Still no role for targeting PI3K pathway in mCRPC – Arun Azad

Now online Clinical Cancer Research- Phase IB study ipatasertib plus ipatasertib in mCR prostate cancer post-NHA. No evidence of synergistic or additive antitumor activity. No clear signal of benefit in biomarker +ve populations either.

My take: Still no role for targeting PI3K pathway in mCRPC

 

Source: Arun Azad/Twitter